E!8498 QuantumX-UOT, Deep Light Vision AB
Reference number | |
Coordinator | Deep Light Vision AB |
Funding from Vinnova | SEK 4 291 989 |
Project duration | September 2025 - February 2028 |
Status | Ongoing |
Venture | Eurostars |
Purpose and goal
Development of a medical device, which can be used in clinical studies, based on "ultrasound optical tomography", UOT. UOT combines the high image resolution of ultrasound with functional information provided by laser spectroscopy. To measure the weak UOT signal, quantum-based optical filters, "slow light filters", are required, which are constructed from rare-earth metal-doped crystals that are cooled to cryogenic temperatures (close to absolute zero).
Expected effects and result
In addition to a clinically usable UOT system, the project will represent a major step towards a commercial product, and provide knowledge in several areas related to UOT: optimization of "slow light filters", method development, technical robustness, use cases, algorithm development and software. We aim to investigate the technology for breast cancer diagnostics as a first application in collaboration with researchers and clinicians at Skåne University Hospital.
Planned approach and implementation
Deep Light Vision (DLV) is coordinating the project, which is in collaboration with Pasqal, France (cryostat manufacturer) and AT Crystals, Slovakia (crystal manufacturer). DLV is responsible for the architecture and design of the equipment, and expertise in "slow light filters" and the UOT technology. Pasqal will supply a cryostat for cooling the filters, suitable for a transportable equipment. AT Crystals will supply crystals. Assembly and testing will be carried out by DLV.